This NAD+ precursor shields the heart from injury caused by a chemotherapeutic in rats, preventing the disruption of tissue organization and blood pumping abilities.

womanwithcancerduringchemotherapyrecoveringfromillnessinhospital

Woman,With,Cancer,During,Chemotherapy,Recovering,From,Illness,In,Hospital

Supplementing with NMN protects the heart against chemotherapy-induced heart complications that include disrupted tissue organization and blood pumping abilities.

NR supplementation improves mitochondrial function and affects inflammatory response in heart failure patients

mitochondrion

A study indicates administering NR provides a heart failure therapy by reducing inflammation and improving cardiac function.

How Increasing NAD+ May Protect Humans From Heart Failure

Cardiovascular

NAD+ precursor decreases atrial fibrillation susceptibility and duration in mice.

grey-mouse

NR decreases the susceptibility for atrial fibrillation along with its duration.

Rodent Study Shows NMN Protects the Heart from Chemotherapy Toxicity

Preliminary Clinical Trial Data Shows NAD+ Improves Inflammatory Response in Heart Failure

The Nampt/NAD+ Axis may be a Potent Therapeutic Target for Individuals with Atrial Fibrillation